WHO ICTRP trial

Evaluation of the anti-cariogenic effect of chitosan–nano amorphous calcium…

IRCT20220219054065N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting

Key facts

Trial ID IRCT20220219054065N1
Public title Evaluation of the anti-cariogenic effect of chitosan–nano amorphous calcium phosphate and chitosan-nano hydroxyapatite varnish
Scientific title Evaluation of the anti-cariogenic effect of chitosan–nano amorphous calcium phosphate and chitosan-nano hydroxyapatite varnish around orthodontic brackets; A Randomized clinical trial
Primary sponsor Shiraz University of Medical Sciences
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Dental caries.
Interventions Intervention 1: First group : Chitosan-nano hydroxyapatite. CMC will be prepared by Hangzhou New Asia Intrernational Co.,Ltd,China ). HA ( Ca10(Po4) 6(OH)2 , white powder , size of nano particles < 50 nm ) will be prepared by Tamadkala…
Registration date Feb 24, 2022
Target size 120
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations